Adi Raviv Email & Phone Number

New York, Ny, Us

Our emphasis is placed on addressing meaningful patient care issues significantly impacting today's healthcare landscape with a focus on existing products that have seen little innovation or have otherwise been overlooked. Our current suite of medical devices are centered around improving the ease and accuracy of pharmaceutical delivery and providing a better healthcare experience for both patients and caregivers.

Jerusalem, Jerusalem, Il

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. Leveraging our state-of-the-art GMP facility, Scinai’s CDMO business unit serves pharmaceutical, biotech, and alternative protein food tech companies with pilot and clinical process development and manufacturing.

Wesley Chapel, Florida, Us

A clinical-stage biopharma company pioneering next generation immunomodulatory vaccines and immunotherapy treatments.

Wilmington, De, Us

SFS finances the future of small business with technology and insight where banks 'fear to lend'. The Company provides alternative funding solutions to a wide range of businesses including retailers, restaurants, hotels, medical professionals, manufacturers, wholesalers and automotive dealers and suppliers. Using proprietary technology, SFS works directly with business owners to obtain quick approvals for tailored financing to meet their goals. The Company's business finance solutions include Cash Advance, Revenue-Based Financing (ACH), Term Loans and Asset-Based Lending, Receivables Factoring, Motor Vehicle Dealer Finance, Medical Practice Financing and Patient Credit Programs.• Responsible for departments that oversee client and corporate accounting, cash management, collections and legal, financial analysis, tax and treasury.• Managed growth of revenues by 126%, an increase of EBITDA by 193% and rise of Net Income by almost 185% from 2009 to 2013. • Successfully negotiated, closed and maintain commercial bank revolving credit facility (increased and extended 4 times and now includes a second lender) with daily reconciliations and borrowing requests.• Raised and participated in subordinated second lien credit vehicle in 2012-13, short-term bridge note funding in 2013 and created off-balance sheet financing instruments to add liquidity while maintaining ability to preserve revenue growth.• Member of 3 person senior executive management team.• Active participant in all Board of Director meetings.

• Brought in by interim CEO (former U.S. Wireless Data CEO) as interim executive/advisor.• Oversaw finance/accounting group consisting of 17 professionals.• Assisted in preparation of company for successful bankruptcy filing and sale.• Coordinated activities of outside forensic accountants responsible for providing information required to restate financial statements and prepare for new audit.• Worked with CRO to establish new processes and procedures for controlling cash flow. Supported analysis of economics of RIF program implemented in May 2009.

Mitchel Field, Ny, 11553, Us

Focused on offering high alpha products to investors with minimal correlation to traditional asset classes; provide fund managers with strategic, business development and third party marketing services. Group arranged meetings to pre-qualify prospective investors, accompanied managers to investor presentations, prepared marketing materials, followed up with prospective investors, and acted as a liaison throughout the investment period. • Managed group comprised of alternative investment, cash management, equity, fixed income and investment banking professionals. • Identified, analyzed and accessed intriguing ideas in the marketplace.• Developed market intelligence and identified prospective investors.• Worked within institutional division to broaden product offering/distribution network.

-Oversaw management and administration of office;-Assisted with asset allocation/investment management activities;-Responsible for providing personal cash flow management, budgeting and financial planning services; and,-Coordinated tax planning, compliance and trust accounting and reporting.

• Oversaw Chapter 11 reorganization efforts, DIP financing and related asset sales.• Responsible for finance (i.e., accounting, corporate finance, SEC reporting, tax and treasury), legal, administration, and investor relations functions.• Reduced operating expenses in excess of $11 million in one year while improving EBITDA loss by over $14 million.• Collaborated on sale of division for $5 million in proceeds.• Restructured real estate and capital leases generating cash savings of over $500,000.• Implemented first corporate accounts receivable factoring program.• Successfully negotiated $2.75 million bridge loan facility.• Finalized exclusive multi-year, multi-million dollar agreement with PepsiCo, Inc.• Member of Executive Committee, active participant in Board of Director meetings.

• Initiated and orchestrated merger of Tower Hill Securities into Walnut Financial Services, a publicly traded venture capital firm, to create THCG.• Completed $7 million private placement concurrent with merger. • Raised additional $12 million ‘on balance sheet’ financings:* $7 million warrant call and exercise* $5 million heavily negotiated convertible preferred from one investor• Formed $18 million affiliated venture capital fund. • Acquired two businesses (one in US for $20 million, one in Israel for $7.5 million). • Achieved market capitalization of almost $400 million at peak.

Mba, Finance, International Business

Ba, International Relations, Economics